Department of Stomatology, A.C. Camargo Cancer Center, São Paulo, Brazil.
School of Dentistry, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Eur J Dent Educ. 2024 May;28(2):497-503. doi: 10.1111/eje.12974. Epub 2023 Nov 10.
OBJECTIVES: To evaluate the knowledge of senior dental students and newly graduated dentists about the prevention, diagnosis and treatment of oral manifestations of syphilis. MATERIALS AND METHODS: A 32-question questionnaire was designed with three domains: (I) demographic, academic and professional data of the participants, (II) attitudes, practices and self-perception regarding training about syphilis and (III) knowledge about syphilis. All knowledge responses were classified as correct or incorrect. Scores ranging from 1 to 14 were calculated, and grades were assigned to each participant according to their level of knowledge. RESULTS: The sample comprised 408 dental students and 339 newly graduated dentists. The mean score was 7.70 ± 3.35 for undergraduates and 9.09 ± 3265 for dentists. The highest frequency of correct answers (>70%) was attributed to questions about the aetiology, transmission and treatment of syphilis. The questions with the lowest frequency of correct answers (<50%) were about the identification of oral manifestations and stages of syphilis. CONCLUSIONS: The knowledge of dental practitioners and academics about the oral manifestations of syphilis was unsatisfactory. The lack of understanding of these aspects can delay the diagnosis and treatment of patients with this disease, which is concerning given the steady increase in cases in recent years.
目的:评估高年级牙科学学生和新毕业牙医对梅毒口腔表现的预防、诊断和治疗的了解。
材料和方法:设计了一个包含 32 个问题的问卷,分为三个领域:(I)参与者的人口统计学、学术和专业数据,(II)关于梅毒培训的态度、实践和自我认知,以及(III)梅毒知识。所有知识回答均分为正确或错误。计算了 1 到 14 的分数,并根据参与者的知识水平为每位参与者分配了等级。
结果:样本包括 408 名牙科学学生和 339 名新毕业牙医。本科生的平均得分为 7.70±3.35,牙医的平均得分为 9.09±3265。关于梅毒病因、传播和治疗的问题的正确答案比例最高(>70%)。关于识别梅毒的口腔表现和阶段的问题的正确答案比例最低(<50%)。
结论:牙科医生和学者对梅毒口腔表现的了解并不令人满意。对这些方面的理解不足可能会延迟对患有这种疾病的患者的诊断和治疗,鉴于近年来病例稳步增加,这令人担忧。
Int J STD AIDS. 2023-5
Asian Pac J Cancer Prev. 2022-2-1